Effect of experimental analogs of contingency management treatment on cocaine seeking behavior
Mark K Greenwald, David M Ledgerwood, Leslie H Lundahl, Caren L Steinmiller, Mark K Greenwald, David M Ledgerwood, Leslie H Lundahl, Caren L Steinmiller
Abstract
Background: Contingency management (CM) treatment is effective for treating cocaine dependence but further mechanistic studies of its efficacy are warranted. This study aimed to determine whether: (a) higher vs. lower predictable money amounts ($3 vs. $1; analogs of standard voucher-based CM) increase cocaine demand elasticity; and (b) probabilistic amounts matched for expected value with the $3-predictable amount (50% chance of $6; 25% chance of $12; and 12.5% chance of $24; analogs of prize CM) similarly affect cocaine choice.
Methods: Each of 15 cocaine-dependent participants first completed a qualifying session to ensure that intranasal cocaine functioned as a reinforcer, then completed a 10-session, within-subject, randomized crossover study. During each of the 10 sessions, the participant responded on a progressive ratio schedule to earn units of cocaine (5-mg or 10-mg) and/or money (five monetary conditions above).
Results: During the reinforcement qualifying session (10-mg vs. 0-mg units; no money alternative), cocaine choice was high. The $3-predictable amount significantly decreased cocaine choice relative to both the $1-predictable amount and the qualifying session. Cocaine-choices in the probabilistic conditions were similar to the $3 predictable condition.
Conclusions: These findings indicate that CM interventions targeted at reducing cocaine self-administration are more likely to succeed with higher value non-drug reinforcement.
Trial registration: ClinicalTrials.gov NCT00946660.
Keywords: Cocaine; Contingency management; Magnitude; Probability; Self-administration.
Conflict of interest statement
Conflict of interest
The authors declare no conflicts of interest in relationship to performing this study.
Copyright © 2014. Published by Elsevier Ireland Ltd.
Figures
Source: PubMed